[Present and future treatment of age-related macular degeneration].
Verougstraete
C
C
Centres Hospitaliers Universitaires Brugmann et Saint-Pierre, Bruxelles.
D000818:Animals; D002986:Clinical Trials as Topic; D004035:Diet Therapy; D005544:Forecasting; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008028:Light Coagulation / Q000379:methods / Q000639:trends; D008268:Macular Degeneration / Q000628:therapy*; D009389:Neovascularization, Pathologic / Q000601:surgery; D010431:Pentoxifylline / Q000627:therapeutic use; D010778:Photochemotherapy; D011994:Recombinant Proteins; D012160:Retina / Q000601:surgery; D013792:Thalidomide / Q000627:therapeutic use
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D013792:Thalidomide; D010431:Pentoxifylline